Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,572,000
+68,000 (4.52%)
At close: Apr 1, 2026
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 72.77 trillion as of April 1, 2026. Its market cap has decreased by -11.86% in one year.
Market Cap
72.77T
Enterprise Value
72.24T
Revenue
4.56T
Ranking
n/a
PE Ratio
40.78
Stock Price
1,572,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 72.77T, an increase of 663.76%. That is a compound annual growth rate of 24.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 69.62T | -11.27% |
| Dec 30, 2025 | 78.46T | 16.17% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 43.13T |
| ALTEOGEN | 18.27T |
| Samsung Epis Holdings | 12.29T |
| SK Biopharmaceuticals | 7.74T |
| Peptron | 7.18T |
| LigaChem Biosciences | 6.99T |
| HLB Co., Ltd. | 6.72T |
| Voronoi | 5.52T |